Mike Nohaile, Angel Investor

Mike Nohaile is a biotech executive and investor with extensive experience leading innovation at the intersection of science and business. He currently serves as CEO of Prellis Biologics, a company advancing breakthroughs in tissue engineering and 3D bioprinting technologies. Before joining Prellis, Mike was Chief Scientific Officer at Generate: Biomedicines and an Operating Partner at Flagship Pioneering. Earlier, he spent over eight years at Amgen as Senior Vice President of Strategy, Commercialization, and Innovation, helping drive the company’s global growth and portfolio development. An active investor in health and life sciences, Mike has invested in ventures such as Bluenote Health, a digital health company enhancing patient care through technology-driven solutions.